Skip to main content

Table 1 Distribution of CBC case and unilateral breast cancer controls

From: Change of mammographic density predicts the risk of contralateral breast cancer - a case-control study

  

Cases

Controls

P-value*

Age at (first) diagnosis (%)

≤45 years

37 (18)

37 (18)

 
 

45 to 55 years

68 (32)

68 (32)

 
 

55 to 65 years

56 (27)

56 (27)

 
 

≥65 years

50 (24)

50 (24)

-

Calendar period of (first) diagnosis (%)

1976 to 1980

31 (15)

30 (14)

 
 

1981 to 1985

40 (19)

41 (19)

 
 

1986 to 1990

45 (21)

41 (19)

 
 

1991 to 1995

51 (24)

49 (23)

 
 

1996 to 2005

44 (21)

50 (24)

-

Adjuvant therapy (%)*

No adjuvant therapy

39 (18)

39 (18)

 
 

Radiotherapy only

57 (27)

57 (27)

 
 

Endocrine therapy

87 (41)

87 (41)

 
 

Chemotherapy

28 (13)

28 (13)

-

Mean follow-up time in years

 

8.25

8.25

-

Percent density at (first) diagnosis (%)

≤5%

13 (6)

11 (5)

 
 

5 to 25%

87 (41)

87 (41)

 
 

25 to 50%

97 (46)

87 (41)

 
 

≥50%

14 (7)

26 (12)

0.23

 

Quartiles:

   

Dense area at (first) diagnosis (%)

≤20 cm2

55 (26)

55 (26)

 
 

20 to 34 cm2

44 (21)

56 (27)

 
 

34 to 53 cm2

56 (27)

49 (23)

 
 

≥53 cm2

56 (27)

51 (24)

0.79

Change in percent density until first

Absolute decrease (>10%)

40 (19)

56 (27)

 

follow-up mammogram (%)

Stable density

164 (78)

143 (68)

 
 

Absolute increase (>10%)

7 (3)

12 (6)

0.07

Change in dense area until first

Absolute decrease (>10 cm2)

61 (29)

75 (36)

 

follow-up mammogram

Stable density

131 (62)

113 (54)

 
 

Absolute increase (>10 cm2)

19 (9)

23 (11)

0.21

 

Quartiles:

   

Non-dense area at (first) diagnosis (%)

≤67 cm2)

42 (20)

60 (28)

 
 

67 to 93 cm2

58 (27)

43 (20)

 
 

93 to 127 cm2

50 (24)

55 (26)

 
 

≥127 cm2

61 (29)

53 (25)

0.10

Mean time until first follow-up mammogram in years (SD)

 

1.56

(0.59)

1.54

(0.57)

0.56

Menopause status at diagnosis (%)**

Premenopausal

89 (42)

84 (40)

 
 

Postmenopausal

119 (56)

124 (59)

0.62

  1. Subdivided by matching variables (age at diagnosis, calendar period of diagnosis, adjuvant therapy and follow-up time), exposure variables (dense area at diagnosis and change of dense area), potential confounding variables (non-dense area at diagnosis and time to first follow-up mammogram), and stratifying variable (menopause status).
  2. * P-value for Chi-square test of association when testing categorical variables and for Student's t-tests when testing the continuous variable (mean time until first follow-up mammogram).
  3. *Endocrine therapy may be with or without radiotherapy, chemotherapy may be with or without radiotherapy and/or endocrine therapy.
  4. ** Six patients had uncertain menopause status (for example, hysterectomy).